State of Wyoming’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91.2K Sell
54,267
-1,262
-2% -$1.83K 0.01% 1425
2026
Q1
$73.3K Buy
55,529
+48,255
+663% +$86.3K 0.01% 1380
2025
Q4
$13.6K Buy
+7,274
New +$14K ﹤0.01% 1717
2025
Q2
Sell
-6,507
Closed -$7.68K 2035
2025
Q1
$7.68K Sell
6,507
-107
-2% -$164 ﹤0.01% 1581
2024
Q4
$12.1K Buy
6,614
+1,579
+31% +$3.08K ﹤0.01% 1530
2024
Q3
$8.56K Buy
5,035
+878
+21% +$1.44K ﹤0.01% 1617
2024
Q2
$5.7K Buy
+4,157
New +$8.39K ﹤0.01% 1594
2023
Q3
Sell
-406
Closed -$5.4K 1762
2023
Q2
$5.4K Buy
+406
New +$4.93K ﹤0.01% 1488
2022
Q3
Sell
-463
Closed -$2K 1824
2022
Q2
$2K Buy
463
+111
+32% +$674 ﹤0.01% 1783
2022
Q1
$3K Buy
352
+59
+20% +$679 ﹤0.01% 1688
2021
Q4
$6K Buy
293
+111
+61% +$2.68K ﹤0.01% 1709
2021
Q3
$5K Sell
182
-87
-32% -$2.58K ﹤0.01% 1092
2021
Q2
$9K Buy
269
+143
+113% +$4.16K 0.01% 1026
2021
Q1
$4K Buy
+126
New +$4.41K 0.01% 449

Other funds holding PACB

State of Wyoming's PACB Position: Q2 2026 in Review

State of Wyoming reduced its Pacific Biosciences (PACB) stake by 2.3% in Q2 2026, selling an estimated $1.83K and leaving 54,267 shares worth $91.2K. The position accounts for 0.01% of the portfolio, ranked #1425.

State of Wyoming first reported a position in PACB in Q1 2021 and has held it in 14 quarters since. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • State of Wyoming held 54,267 shares of Pacific Biosciences worth $91.2K as of Q2 2026.
  • State of Wyoming sold 1,262 Pacific Biosciences shares in Q2 2026, an estimated $1.83K.
  • Pacific Biosciences made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1425 holding.
  • State of Wyoming first reported a position in Pacific Biosciences in Q1 2021 and has held it in 14 quarters since.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.